Overview of ALK and ROS1 rearranged lung cancer

8Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Many attempts have been made to find genetic abnormalities inducing carcinogenesis after the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor targeting EGFR in lung cancer. New target therapies have been already commercialized and studied along with the recent discovery of gene rearrangement involved in the carcinogenic process of non-small cell lung cancer. This study aims to investigate anplastic lymphoma kinase, c-ros oncogene 1, and receptor tyrosine kinase, in particular. © 2013 The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Cite

CITATION STYLE

APA

Choi, C. M. (2013). Overview of ALK and ROS1 rearranged lung cancer. Tuberculosis and Respiratory Diseases. https://doi.org/10.4046/trd.2013.75.6.236

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free